Priority Technology Holdings, Inc.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
16. Earnings (Loss) per Common Share
- Earnings (Loss) per Common Share
The following tables set forth the computation of the Company's basic and diluted earnings (loss) per common share:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| (in thousands except per share amounts) | 2025 | 2024 | 2025 | 2024 |
| Numerator: | ||||
| Net income | $27,588 | $10,608 | $46,735 | $16,795 |
| Less: Dividends and accretion attributable to redeemable senior preferred stockholders | — | (5,121) | — | (36,348) |
| Less: Return on redeemable NCI | — | — | — | (639) |
| Net income (loss) attributable to common stockholders | $27,588 | $5,487 | $46,735 | $(20,192) |
| Weighted average shares outstanding(1) | 80,325 | 77,973 | 79,366 | 77,910 |
| Effect of dilutive potential common shares | 791 | 2,122 | 1,017 | — |
| Adjusted Weighted average shares outstanding | 81,116 | 80,095 | 80,383 | 77,910 |
| Basic Earnings (loss) per common share | $0.34 | $0.07 | $0.59 | $(0.26) |
| Diluted Earnings (loss) per share | $0.34 | $0.07 | $0.58 | $(0.26) |
(1)For the three and nine months ended September 30, 2024, the weighted-average common shares outstanding includes 1,803,841 warrants. These shares of common stock had an exercise price of $0.001 and were exercised on January 14, 2025. The warrants are considered to be equity contracts indexed in the Company's own shares and therefore were recorded at their inception date relative fair value and are included in additional paid-in capital on the Company's Unaudited Consolidated Balance Sheets.
For the three and nine months ended September 30, 2025, the Company had 0.8 million and 1.0 million, respectively, dilutive securities that were included in the Company's diluted earnings per share. For the three and nine months ended September 30, 2024, the Company had 2.1 million and 0.0 million, respectively, dilutive securities that were included in the Company's diluted earnings per share. Anti-dilutive securities that were excluded from the Company's earnings (loss) per common share are as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| (number of shares, in thousands) | 2025 | 2024 | 2025 | 2024 |
| Restricted stock awards(1) | 12 | 42 | 1 | 788 |
| Liability-classified restricted stock units | — | — | — | — |
| Outstanding stock option awards(1) | — | 855 | — | 865 |
| Total | 12 | 897 | 1 | 1,653 |
(1)Granted under the 2018 Plan.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.